Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hicks

Showing results (351-360 of 466) with videos related to

Pageof 47
Sort By:
Inorganic Chemistry|May 12, 2009
Effects of electron-deficient beta-diketiminate and formazan supporting ligands on copper(I)-mediated dioxygen activationSungjun Hong, Lyndal M R Hill, Aalo K Gupta, et al.
Oncogene|October 9, 1998
Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damageL L Kelley, G G Hicks, F F Hsieh, et al.
Journal of the National Cancer Institute|October 24, 2012
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissuesVeronique M Neumeister, Valsamo Anagnostou, Summar Siddiqui, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2026
Inhibition of FicD-mediated AMPylation and deAMPylation by isoprenoid diphosphatesAubrie M Blevins, Wei Peng, Lisa N Kinch, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 25, 2014
Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic timeMaria Vassilakopoulou, Fabio Parisi, Summar Siddiqui, et al.
Human Pathology|May 14, 2005
The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization studyDavid G Hicks, Brian J Yoder, James Pettay, et al.
Breast Cancer : Basic and Clinical Research|August 11, 2010
The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell LinesKristina Subik, Jin-Feng Lee, Laurie Baxter, et al.
Journal of Molecular Biology|February 7, 2007
An essential role for the DnaK molecular chaperone in stabilizing over-expressed substrate proteins of the bacterial twin-arginine translocation pathwayRitsdeliz Pérez-Rodríguez, Adam C Fisher, Jason D Perlmutter, et al.
American Journal of Clinical Pathology|June 2, 2023
HER2 in uterine serous carcinoma: Current state and clinical perspectivesJanira M Navarro Sanchez, Brian S Finkelman, Bradley M Turner, et al.
Human Pathology|May 22, 2012
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumorHiroshi Miyamoto, Koji Izumi, Jorge L Yao, et al.
Pageof 47

Showing results (351-360 of 466) with videos related to

Sort By:
Pageof 47
Inorganic Chemistry|May 12, 2009
Effects of electron-deficient beta-diketiminate and formazan supporting ligands on copper(I)-mediated dioxygen activationSungjun Hong, Lyndal M R Hill, Aalo K Gupta, et al.
Oncogene|October 9, 1998
Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damageL L Kelley, G G Hicks, F F Hsieh, et al.
Journal of the National Cancer Institute|October 24, 2012
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissuesVeronique M Neumeister, Valsamo Anagnostou, Summar Siddiqui, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2026
Inhibition of FicD-mediated AMPylation and deAMPylation by isoprenoid diphosphatesAubrie M Blevins, Wei Peng, Lisa N Kinch, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 25, 2014
Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic timeMaria Vassilakopoulou, Fabio Parisi, Summar Siddiqui, et al.
Human Pathology|May 14, 2005
The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization studyDavid G Hicks, Brian J Yoder, James Pettay, et al.
Breast Cancer : Basic and Clinical Research|August 11, 2010
The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell LinesKristina Subik, Jin-Feng Lee, Laurie Baxter, et al.
Journal of Molecular Biology|February 7, 2007
An essential role for the DnaK molecular chaperone in stabilizing over-expressed substrate proteins of the bacterial twin-arginine translocation pathwayRitsdeliz Pérez-Rodríguez, Adam C Fisher, Jason D Perlmutter, et al.
American Journal of Clinical Pathology|June 2, 2023
HER2 in uterine serous carcinoma: Current state and clinical perspectivesJanira M Navarro Sanchez, Brian S Finkelman, Bradley M Turner, et al.
Human Pathology|May 22, 2012
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumorHiroshi Miyamoto, Koji Izumi, Jorge L Yao, et al.
Pageof 47